XML Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $318K | Buy |
605
+13
| +2% | +$6.83K | 0.03% | 297 |
|
|
2025
Q1 | $375K | Sell |
592
-452
| -43% | -$287K | 0.04% | 260 |
|
|
2024
Q4 | $744K | Sell |
1,044
-63
| -6% | -$44.9K | 0.07% | 192 |
|
|
2024
Q3 | $1.16M | Sell |
1,107
-100
| -8% | -$105K | 0.11% | 158 |
|
|
2024
Q2 | $1.27M | Sell |
1,207
-30
| -2% | -$31.5K | 0.13% | 142 |
|
|
2024
Q1 | $1.19M | Sell |
1,237
-20
| -2% | -$19.3K | 0.12% | 151 |
|
|
2023
Q4 | $1.1M | Buy |
1,257
+48
| +4% | +$42.2K | 0.12% | 153 |
|
|
2023
Q3 | $995K | Sell |
1,209
-16
| -1% | -$13.2K | 0.12% | 152 |
|
|
2023
Q2 | $880K | Buy |
1,225
+61
| +5% | +$43.8K | 0.1% | 170 |
|
|
2023
Q1 | $956K | Sell |
1,164
-90
| -7% | -$74K | 0.12% | 151 |
|
|
2022
Q4 | $905K | Sell |
1,254
-30
| -2% | -$21.6K | 0.11% | 155 |
|
|
2022
Q3 | $885K | Buy |
1,284
+52
| +4% | +$35.8K | 0.12% | 149 |
|
|
2022
Q2 | $728K | Buy |
1,232
+160
| +15% | +$94.5K | 0.16% | 110 |
|
|
2022
Q1 | $749K | Buy |
1,072
+89
| +9% | +$62.2K | 0.09% | 175 |
|
|
2021
Q4 | $621K | Sell |
983
-20
| -2% | -$12.6K | 0.07% | 184 |
|
|
2021
Q3 | $607K | Buy |
1,003
+105
| +12% | +$63.5K | 0.08% | 184 |
|
|
2021
Q2 | $502K | Buy |
898
+3
| +0.3% | +$1.68K | 0.11% | 143 |
|
|
2021
Q1 | $423K | Buy |
895
+268
| +43% | +$127K | 0.1% | 146 |
|
|
2020
Q4 | $303K | Buy |
627
+5
| +0.8% | +$2.42K | 0.08% | 163 |
|
|
2020
Q3 | $348K | Sell |
622
-100
| -14% | -$55.9K | 0.11% | 140 |
|
|
2020
Q2 | $450K | Sell |
722
-131
| -15% | -$81.6K | 0.16% | 107 |
|
|
2020
Q1 | $417K | Buy |
853
+13
| +2% | +$6.36K | 0.18% | 99 |
|
|
2019
Q4 | $315K | Buy |
+840
| New | +$315K | 0.11% | 136 |
|